Genomic Health's Q1 Revenues Rise 6 Percent | GenomeWeb

NEW YORK (GenomeWeb) – Genomic Health reported after the close of the market Tuesday that its first quarter revenues were up 6 percent year over year driven by increased sales for its Oncotype DX tests.

The Redwood City, Calif.-based molecular diagnostics firm brought in total revenues of $67 million for the three months ended March 31, up from $63.1 million in the first quarter of 2013 but below the consensus Wall Street estimate of $68.5 million. All of its revenue in the most recent quarter came from product sales.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.